Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Outlook Therapeutics Inc., 3 years.
Outlook Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Outlook Therapeutics Inc. March 10, 202692.4%
-
Outlook Therapeutics Inc. March 30, 202398.3%
-
Outlook Therapeutics Inc. March 29, 202398.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Outlook Therapeutics Inc. | Open-market purchase | +95,398 | $1.05 | $99,996 |
| May 27, 2026 | Outlook Therapeutics Inc. | Open-market purchase | +122,174 | $0.41 | $50,091 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.